Yale chemists forge a new path in the search for antibiotics
The discovery comes at a time when more types of bacteria are becoming resistant to existing antibiotics, increasing the occurrence of lethal infections. The ability to create new antibiotics would have significant ramifications for medical treatment and public health, said the researchers.
“This is one way to focus our talents as synthetic chemists in a direction that can immediately help patients,” said Seth Herzon, a chemistry professor at Yale and member of the Yale Cancer Center. Herzon is principal investigator of a new study published June 1 in the journal Science.
Yale postdoctoral fellow Stephen Murphy and Yale graduate student Mingshuo Zeng are co-authors of the study. Both are members of the Herzon Lab.
The new process makes it possible to create molecules related to the natural product pleuromutilin from simple commercial chemicals in the laboratory. Pleuromutilin is produced by a fungus and was found to have useful antibacterial properties in the early 1950s. Since then, scientists in academia and the pharmaceutical industry have created thousands of pleuromutilin derivatives by a process known as semisynthesis, which involves chemically modifying pleuromutilin itself. However, a large proportion of these derivatives only vary at a single position in the molecule. A practical full synthesis, which would make a wealth of additional antibiotics possible, has remained elusive.
Herzon first attempted to find a solution in 2008. “We worked on this project for a few years when I started at Yale, but didn’t record much success,” Herzon said. “The pharmaceutical industry has historically been the driving force behind antibiotics development. However, antibiotics are essentially at the bottom of the list in terms of investment return. Consequently, most major pharmaceuticals have walked away from this area.”
This has led to a dearth of new drugs to combat resistance, Herzon added. “As the anti-bacterial crisis kept getting worse, we decided we had to pick this back up and conceive an entirely different approach,” he said.
Herzon and his colleagues discovered they could prepare an isomer of pleuromutilin — a compound that has the same connectivity, but with a different arrangement of atoms — and rearrange it in the final steps of the synthesis to pleuromutilin. The discovery allowed the group to vault past some of the previous roadblocks and achieve the full synthesis of pleuromutilin. Moreover, these isomers have better antibacterial properties than pleuromutilin itself, opening the door to the preparation of improved compounds.
“Making pleuromutilin is great, but we are more interested in the non-natural compounds we can access through synthesis. We’re continuing to refine the synthesis, and the sky is the limit now, in terms of the modifications we can make,” Herzon explained. “We’re going to start testing compounds immediately. If all goes well we ultimately hope to move our compounds into clinical trials to treat drug-resistant infections.”
The Latest on: Antibiotics
New Research Points To The Future Of Antibiotics
on April 17, 2018 at 1:08 am
Newly discovered antibiotics could be crucial in fighting drug-resistant bacteria. Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France discovered the new class of antibiotics, as told in an ... […]
Antibiotics Reduced Efficacy of Checkpoint Inhibitors in RCC, NSCLC
on April 16, 2018 at 12:39 pm
Use of antibiotics may be associated with reduced effectiveness of immune checkpoint inhibitors (ICIs) for patients with advanced renal cell carcinoma (RCC) and non-small-cell lung cancer (NSCLC), according to the results of a study published in Annals of ... […]
New class of antibiotics to combat drug resistance
on April 15, 2018 at 12:08 pm
Chicago - A new class of antibiotic has been discovered. The chemical kills bacteria by binding to ribosome. This disrupts protein synthesis, and stops the microbial cell from replicating. This is a step forward in the search for new antimicrobials. […]
Treated Farm Waste Contains Traces Of Antibiotics, Possibly Contributing To Spread Of Resistance
on April 13, 2018 at 3:30 pm
After analyzing two of the “most elite” waste treatment systems on farms today, two studies from the University at Buffalo found that antibiotics aren’t fully removed from the manure. Instead, the waste still contains antibiotics that may be ... […]
Remnants Of Antibiotics Persist In Treated Farm Waste
on April 12, 2018 at 7:20 pm
Each year, farmers in the U.S. purchase tens of millions of pounds of antibiotics that are approved for use in cows, pigs, fowl and other livestock. When farmers repurpose the animals’ manure as fertilizer or bedding, traces of the medicines leach into ... […]
via Google News and Bing News